New hepatitis medicines ‘pay for themselves’

A report into the value that Australians receive from government-subsidised medicines has highlighted the need to address spiralling rates of liver disease by adding breakthrough hepatitis C medicines to the PBS, says Hepatitis Australia. Hepatitis Australia today responded to research revealing that premature deaths in Australia from liver disease fell by 3% between 1998 and